Table of Contents

Articles

• You have access

  Development of Novel CH223191-Based Antagonists of the Aryl Hydrocarbon Receptor

  Eun-Young Choi, Hyosung Lee, R. W. Cameron Dingle, Kyung Bo Kim and Hollie I. Swanson

  Molecular Pharmacology January 2012, 81 (1) 3-11; DOI: https://doi.org/10.1124/mol.111.073643
• You have access

  Estrogen Receptors and Type 1 Metabotropic Glutamate Receptors Are Interdependent in Protecting Cortical Neurons against β-Amyloid Toxicity

  Simona Federica Spampinato, Gemma Molinaro, Sara Merlo, Luisa Iacovelli, Filippo Caraci, Giuseppe Battaglia, Ferdinando Nicoletti, Valeria Bruno and Maria Angela Sortino

  Molecular Pharmacology January 2012, 81 (1) 12-20; DOI: https://doi.org/10.1124/mol.111.074021
• You have access

  The LRRC26 Protein Selectively Alters the Efficacy of BK Channel Activators

  Janos Almassy and Ted Begenisich

  Molecular Pharmacology January 2012, 81 (1) 21-30; DOI: https://doi.org/10.1124/mol.111.075234
• You have access

  Diflavin Oxidoreductases Activate the Bioreductive Prodrug PR-104A under Hypoxia

  Christopher P. Guise, Maria R. Abbattista, Smitha R. Tipparaju, Neil K. Lambie, Jiechuang Su, Dan Li, William R. Wilson, Gabi U. Dachs and Adam V. Patterson

  Molecular Pharmacology January 2012, 81 (1) 31-40; DOI: https://doi.org/10.1124/mol.111.073759
• You have access

  Probe Dependence in the Allosteric Modulation of a G Protein-Coupled Receptor: Implications for Detection and Validation of Allosteric Ligand Effects

  Celine Valant, Christian C. Felder, Patrick M. Sexton and Arthur Christopoulos

  Molecular Pharmacology January 2012, 81 (1) 41-52; DOI: https://doi.org/10.1124/mol.111.074872
• You have access

  Designing Calcium Release Channel Inhibitors with Enhanced Electron Donor Properties: Stabilizing the Closed State of Ryanodine Receptor Type 1

  Yanping Ye, Daniel Yaeger, Laura J. Owen, Jorge O. Escobedo, Jialu Wang, Jeffrey D. Singer, Robert M. Strongin and Jonathan J. Abramson

  Molecular Pharmacology January 2012, 81 (1) 53-62; DOI: https://doi.org/10.1124/mol.111.074740
• You have access

  Modeling Human Cytochrome P450 2D6 Metabolism and Drug-Drug Interaction by a Novel Panel of Knockout and Humanized Mouse Lines

  Nico Scheer, Yury Kapelyukh, Jillian McEwan, Vincent Beuger, Lesley A. Stanley, Anja Rode and C. Roland Wolf

  Molecular Pharmacology January 2012, 81 (1) 63-72; DOI: https://doi.org/10.1124/mol.111.075192
• You have access

  Tyrosine Phosphorylation of the Human Serotonin Transporter: A Role in the Transporter Stability and Function

  Balasubramaniam Annamalai, Padmanabhan Mannangatti, Obulakshmi Arapulisamy, Toni S. Shippenberg, Lankupalle D. Jayanthi and Sammanda Ramamoorthy

  Molecular Pharmacology January 2012, 81 (1) 73-85; DOI: https://doi.org/10.1124/mol.111.073171
• You have access

  The Role of CYP3A4 mRNA Transcript with Shortened 3′-Untranslated Region in Hepatocyte Differentiation, Liver Development, and Response to Drug Induction

  Dan Li, Roger Gaedigk, Steven N. Hart, J. Steven Leeder and Xiao-bo Zhong

  Molecular Pharmacology January 2012, 81 (1) 86-96; DOI: https://doi.org/10.1124/mol.111.074393
• You have access

  The Activity of Human Aquaporin 1 as a cGMP-Gated Cation Channel Is Regulated by Tyrosine Phosphorylation in the Carboxyl-Terminal Domain

  Ewan M. Campbell, Dawn N. Birdsell and Andrea J. Yool

  Molecular Pharmacology January 2012, 81 (1) 97-105; DOI: https://doi.org/10.1124/mol.111.073692